Header cover image

Investing Ideas
/
Hong Kong Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20

Hong Kong Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20

Results

6

0 new

A list of companies that grew earnings by 20% and are trading on less than 20 times earnings. All with a debt to equity ratio below 1.

6 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
	3933 United Laboratories International Holdings	HK$10.12	-5.9%	34.2%	HK$18.4b	HK$11.97	PE5.9x	E3.9%	5.9%
	6826 Shanghai Haohai Biological Technology	HK$29.40	-5.8%	-5.9%	HK$15.2b	HK$42.57	PE14.7x	E16.8%	2.9%
	1558 YiChang HEC ChangJiang Pharmaceutical	HK$9.39	4.0%	15.1%	HK$8.3b	HK$13.80	PE4.7x	S2.0%	0%
	2877 China Shineway Pharmaceutical Group	HK$8.33	-9.8%	20.0%	HK$6.3b	HK$12.82	PE5.3x	E8.3%	6.8%
	2348 Dawnrays Pharmaceutical (Holdings)	HK$1.25	-1.6%	15.7%	HK$1.9b	n/a	PE3.1x	n/a	6.2%
	503 Lansen Pharmaceutical Holdings	HK$1.79	0%	23.6%	HK$750.6m	n/a	PE13x	n/a	2.7%

Page 1 of 1